Recent studies demonstrate that KEAP1 downregulates PD-L1 expression in cancer cells via ubiquitination and proteasome-mediated degradation and that overexpression of KEAP1 enhances cytotoxic T cell activation in vivo [92]. Here, KEAP1 is linked to cancer.